Tag: Diabetes
Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for...
The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment
Cipla launches India’s only inhaled insulin, Afrezza
The launch of this product in India is expected to benefit many of the 10 crore adults currently living with diabetes mellitus
Cipla launches Yurpeak for the treatment of Obesity and Type 2...
A prescription medicine to be used under medical advice, it will be available in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg strengths
Diabetes surges among young Indians – Mahajan Imaging & Labs data...
Mahajan Imaging & Labs reports a sharp rise in metabolic and glucose screenings among young adults, mirroring a nationwide trend of early-onset diabetes and increased preventive health testing.
Shoolini University turns brewery waste into diabetic-friendly sweetener, wins four patents
This diabetic-friendly alternative is created by converting brewer’s spent grain (BSG), the primary by-product of beer production, into a high-value, eco-friendly sugar substitute
India must move towards a self-sustainable research ecosystem: Dr Jitendra Singh
Addressing Bengaluru Diabetes Conference, Dr Jitendra Singh calls upon healthcare sector to move away from overdependence on government funding and encourage a culture of extensive private-sector participation
Biocon Biologics and Civica expand partnership to launch private-label Insulin Glargine...
Additional treatment options for the 38.4 million U.S. patients living with diabetes
Lilly’s oral GLP-1 Orforglipron clears third Phase 3 trial, set for...
Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 10.4 kg (10.5%) on the highest dose, with A1C reduced by an average of 1.8%
Home Minister Amit Shah applauds Arjun Deshpande for revolutionizing affordable healthcare...
The recognition marks a significant milestone in 22 year old entrepreneur's journey to revolutionize the pharmaceutical industry and ensure that quality healthcare reaches every Indian at significantly reduced costs
1 in 2 Indians at risk of lifestyle disorders: Redcliffe Labs...
Common lifestyle disorders impacting Indians include Diabetes, Arthritis, Thyroid, and Lipid- in turn leading to increasing cardiovascular issues